期刊文献+

原发及转移性卵巢癌组织中绒毛蛋白、细胞角蛋白7及20的表达 被引量:4

Expression of Villin, CK7,and CK20 in primary and metastatic ovarian carcinoma tissue
下载PDF
导出
摘要 目的:检测原发及转移性卵巢癌组织中绒毛蛋白(Villin)、细胞角蛋白7及20(CK7、CK20)的表达。方法:采用免疫组织化学方法检测卵巢原发性腺癌45例(浆液性腺癌18例、黏液性腺癌15例、内膜样腺癌12例)、结肠转移性卵巢癌15例、原发结肠腺癌20例、正常卵巢组织10例中Villin、CK7和CK20的表达。结果:正常卵巢、原发性卵巢腺癌、结肠转移性卵巢癌及原发性结肠腺癌组织间比较,Villin、CK7和CK20的阳性表达率差异均有统计学意义(P<0.001);且原发卵巢癌组织中Villin的阳性表达率低于CK20(P<0.005)。结论:Villin、CK7和CK20的测定对鉴别原发及转移性卵巢癌有重要意义,Villin在特异性方面强于CK20。 Aim : To investigate the utility of a limited panel consisting of Villin, CK7, and CK20 differentiating primary and metastatic ovarian tumor. Methods: Immunohistochemical detection of Villin, CK7, and CK20 were performed on 45 cases of primary ovarian adenocarcinoma ( 18 cases of serous, 15 cases of mucinous, and 12 cases of endometrioid) , 15 cases of colonic carcinoma metastatic to the ovaries, 20 cases of primary colonic carcinoma, and 10 cases of normal ovary tissue. Results: The positive expression rates of Villin, CK7, and CK20 in normal ovary tissue, primary of ovarian adenocarcinoma tissue, colonic carcinoma metastatic to the ovaries, and primary colonic carcinoma tissue were significantly different ( P 〈 0. 001 ). And the positive expression rate of CK20 was higher than that of Villin in primary ovarian tumor tissue ( P 〈 0. 005 ). Conclusion : A limited panel of Villin, CK7, and CK20 is helpful in distinguishing primary from metastatic ovarian carcinoma. And Villin is more specific than CK20 as it is lower expression in primary ovarian carcinoma.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2007年第2期345-347,共3页 Journal of Zhengzhou University(Medical Sciences)
关键词 绒毛蛋白 卵巢癌 原发性 转移性 细胞角蛋白7 细胞角蛋白20 Villin ovary carcinoma primary metastases CK7 CK20
  • 相关文献

参考文献8

  • 1Kennedy MT,Jordan RC,Berean KW,et al.Expression pattern of CK7,CK20,CDX-2,and villin in intestinal-type sinonasal adenocarcinoma[J].J Clin Pathol,2004,57(9):932
  • 2Baker PM,Oliva E.Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors:an update[J].Int J Gynecol Pathol,2005,24(1):39
  • 3Cathro HP,Stoler MH.Expression of cytokeratins 7 and 20 in ovarian neoplasia[J].Am J Clin Pathol,2002,117(6):944
  • 4Raspollini MR,Amunni G,Villanucci A,et al.Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma:an immunohistochemical comparison of 43 cases[J].Appl Immunohistochem Mol Morphol,2004,12(2):127
  • 5Ji H,Isacson C,Seidman J,et al.Cytokeratins 7 and 20,Dpc4,and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors:Dpc4 assists in identifying metastatic pancreatic carcinomas[J].Int J Gynecol Pathol,2002,21(4):391
  • 6Bacchi CE,Gown AM.Distribution and pattern of expression of villin,a gastrointestinal-associated cytoskeletal protein,in human carcinomas:a study employing paraffin-embedded tissue[J].Lab Invest,1991,64(3):418
  • 7Suh N,Yang XJ,Tretiakova MS,et al.Value of CDX2,villin,and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma[J].Mod Pathol,2005,18(9):1 217
  • 8Nishizuka S,Chen ST,Gwadry FG,et al.Diagnostic markers that distinguish colon and ovarian adenocarcinomas:identification by genomic,proteomic,and tissue array profiling[J].Cancer Res,2003,63(17):5 243

同被引文献40

  • 1赵成波,周成军,郭建强.绒毛蛋白在胃癌及癌前病变中的表达及意义[J].山东大学学报(医学版),2009,47(2):46-49. 被引量:6
  • 2Ashworth T. A case of cancer in which cells similar to those in the tumors were seen in the blood after death[J]. Aust Med J, 1986, 14: 146-149.
  • 3Alva A, Friedlander T, Clark M, et al. Circulating tumor calls as potential biomarkers in bladder cancer[J]. J Urol, 2015, 194 (3) : 790-798. DOI: 10. lO16/j, juro. 2015.02. 2951.
  • 4Kolostova K, Broul M, Schraml J, et al. Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and rela- tionship to T-stage and Gleason score[J]. Anticancer Res, 2014, 34 (7): 3641-3646.
  • 5Poveda A, Kaye SB, Mecormack R, et al. Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer[J]. Gynecol Oncol, 2011, 122(3) : 567-572. DOI: 10. 1016/j. ygyno. 2011.05. 028.
  • 6Ning N, Zhan T, Zhang Y, et 81. Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluo- rescence in situ hybridization[J]. Clin Chim Acta, 2014, 433 : 69- 75. DOI: 10. 1016/j. cca. 2014. 02. 019.
  • 7Pearl blL, Zhao Q, Yang J, et al. Prognostic analysis of invasive cir- culating tumor cells (iCTCs)in epithelial ovarian cancer[J]. Gynecol Oncol, 2014, 134(3): 581-590. DOI: 10. 1016/j. ygyno. 2014. 06. 013.
  • 8Vona G, Sabile A, Louha M, et al. Isolation by size of epithelial tu- mor cells : a new method for the immunomorphological and molec- ular characterization of circulatingtumor cells[J]. Am J Pathol, 2000, 156( 1 ) : 57-63. DOI: 10. 1016/S0002-9440( 10)64706-2.
  • 9Choi H, Kim KB, Jeon CS, et al. A label-free DC impedance-based micmcytometer for circulating rare cancer cell counting[J]. Lab Chip, 2013, 13(5): 970-977. DOI: 10. 1039/c21c41376k.
  • 10Judson PL, Geller MA, Bliss RL, et al. Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer[J]. Gynecol Oncol, 2003, 91 (2) : 389-394. DOI: 10. lO16/j, ygyno. 2003.0g. 004.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部